John M Finn

Title: The Innovations of John M Finn

Introduction

John M Finn is a notable inventor based in Andover, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific receptors in the human body. With a total of 3 patents, his work has the potential to impact various medical conditions.

Latest Patents

One of John M Finn's latest patents is focused on aryl sulfonamides and sulfamide derivatives. This invention is directed to novel aryl sulfonamide and sulfamide compounds that bind selectively to and inhibit the activity of the human Y5 receptor. The applications of these compounds are extensive, as they can be used for the treatment of feeding disorders such as obesity, anorexia nervosa, and bulimia nervosa. Additionally, they may be beneficial in addressing abnormal conditions like sexual/reproductive disorders, depression, epileptic seizures, hypertension, cerebral hemorrhage, congestive heart failure, and sleep disturbances. The versatility of these compounds highlights their potential in treating any disease where antagonism of a Y5 receptor may be useful.

Career Highlights

John M Finn is currently associated with Synaptic Pharmaceutical Corporation, where he continues to innovate and develop new therapeutic solutions. His work is characterized by a commitment to advancing medical science and improving patient outcomes through targeted therapies.

Collaborations

Throughout his career, John has collaborated with talented individuals such as Imadul Islam and Daljit Singh Dhanoa. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

John M Finn's contributions to the field of pharmaceuticals through his innovative patents demonstrate his dedication to addressing complex medical challenges. His work not only showcases his inventive spirit but also holds promise for improving the lives of many individuals facing various health issues.